( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
Audited
UnAudited
Net Sales
117.01
43.36
105.54
97.83
Total Expenditure
93.15
44.18
125.39
86.96
PBIDT (Excl OI)
23.86
-0.82
-19.85
10.87
Other Income
3.07
13.97
-7.13
6.31
Operating Profit
26.93
13.15
-26.98
17.18
Exceptional Items
NA
NA
NA
NA
PBDT
25.27
11.02
-28.03
15.86
Depreciation
1.33
1.29
1.13
1.29
Profit Before Tax
23.94
9.73
-29.16
14.57
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
21.05
6.32
-16.45
18.39
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
21.05
6.32
-16.45
18.39
Minority Interest
0.13
3.31
-0.42
0.03
Shares of Associates
0.42
0.2
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
21.61
9.64
-16.67
18.42
Equity Capital
158.85
158.85
158.85
158.85
Calculated EPS
0.68
0.30
-0.52
0.57
Calculated EPS (Annualised)
2.72
1.21
-2.09
2.31
No of Public Share Holdings
15021176
15021176
15021176
15021176
% of Public Share Holdings
47.28
47.28
47.28
47.28
PBIDTM% (Excl OI)
20.39
-1.89
-18.80
11.11
PBIDTM%
23.01
30.32
-25.56
17.56
PBDTM%
21.59
25.41
-26.55
16.21
PBTM%
20.45
22.44
-27.62
14.89
PATM%
17.98
14.57
-15.58
18.79